Hydralazine hydrochloride and Peripheral swelling - a phase IV clinical study of FDA data
Summary:
Peripheral swelling is reported as a side effect among people who take Hydralazine hydrochloride (hydralazine hydrochloride), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Hydrochlorothiazide, and have Acute lymphocytic leukemia (all).
The phase IV clinical study analyzes which people have Peripheral swelling when taking Hydralazine hydrochloride. It is created by eHealthMe based on reports of 785 people who have side effects when taking Hydralazine hydrochloride from the FDA, and is updated regularly.
What is Hydralazine hydrochloride?
Hydralazine hydrochloride has active ingredients of hydralazine hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 1,238 Hydralazine hydrochloride users. Check the latest studies of Hydralazine hydrochloride.
What is Peripheral swelling?
Peripheral swelling is found to be associated with 2,181 drugs and 1,743 conditions by eHealthMe. Check the latest studies of Peripheral swelling.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
785 people reported to have side effects when taking Hydralazine hydrochloride.
Among them, 15 people (1.91%) have Peripheral swelling.

Among these 15 people:
How long have people been on Hydralazine hydrochloride when they have Peripheral swelling? *
- < 1 month: 25 %
- 1 - 6 months: 50 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 25 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Peripheral swelling when taking Hydralazine hydrochloride? *
- female: 40 %
- male: 60 %
What is the age of people who have Peripheral swelling when taking Hydralazine hydrochloride? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 27.27 %
- 60+: 72.73 %
What are other drugs people take besides Hydralazine hydrochloride? *
- Carvedilol: 3 people, 20.00%
- Aspirin: 3 people, 20.00%
- Fenofibrate: 3 people, 20.00%
- Hydrochlorothiazide: 3 people, 20.00%
- Amlodipine Besylate: 2 people, 13.33%
- Vitamin D: 2 people, 13.33%
- Atenolol: 2 people, 13.33%
- Gabapentin: 2 people, 13.33%
- Metoprolol Succinate: 2 people, 13.33%
- Lisinopril: 2 people, 13.33%
What are other side effects people have besides Peripheral swelling? *
- Joint Pain: 4 people, 26.67%
- Dizziness: 4 people, 26.67%
- Rashes (redness): 3 people, 20.00%
- Weight Increased: 2 people, 13.33%
- Nasopharyngitis (inflammation of the nasopharynx): 2 people, 13.33%
- Haemoglobin Decreased: 2 people, 13.33%
- Pneumonia: 2 people, 13.33%
- Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 13.33%
- Gait Disturbance: 2 people, 13.33%
- Chronic Kidney Disease: 2 people, 13.33%
What are the existing conditions these people have? *
- Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 2 people, 13.33%
- Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 2 people, 13.33%
- Primary Myelofibrosis (primary disorder of the bone marrow): 1 person, 6.67%
- Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 1 person, 6.67%
- Nephritic Syndrome (a collection of signs (known as a syndrome) associated with disorders affecting the kidneys, more specifically glomerular disorders): 1 person, 6.67%
- Hypersensitivity: 1 person, 6.67%
- High Blood Cholesterol: 1 person, 6.67%
- Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 1 person, 6.67%
- Cardiac Failure Congestive: 1 person, 6.67%
- Asthma: 1 person, 6.67%
* Approximation only. Some reports may have incomplete information.
Do you take Hydralazine hydrochloride and have Peripheral swelling?
- Check whether Peripheral swelling is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Hydralazine hydrochloride:
- Hydralazine hydrochloride (1,238 reports)
Peripheral swelling treatments and more:
- Peripheral swelling (168,738 reports)
How severe was Peripheral swelling and when was it recovered:
Expand to all the drugs that have ingredients of hydralazine hydrochloride:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Hydralazine hydrochloride:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Peripheral swelling:
- Peripheral swelling (2,181 drugs)
Browse all the conditions that are associated with Peripheral swelling:
- Peripheral swelling (1,743 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on hydralazine hydrochloride (the active ingredients of Hydralazine hydrochloride) and Hydralazine hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Sandimmune and Protonix - 3 seconds ago
- Could Humira cause Behcet'S Syndrome? - 4 seconds ago
- Could Astepro cause Taste - Impaired? - 5 seconds ago
- Could Lasix cause Blood Fibrinogen Decreased? - 30 seconds ago
- Hypothyroidism and Lung Neoplasm Malignant - 37 seconds ago
- Could Losartan cause Chronic Obstructive Airways Disease? - 39 seconds ago
- Hepatocellular Carcinoma and Immunodeficiency - 47 seconds ago
- Could Thalomid cause Renal Cell Carcinoma Stage Unspecified? - 54 seconds ago
- Gaviscon and Oramorph Sr drug interactions for men aged 60+ - 55 seconds ago
- Fracture Malunion and drugs of ingredients of alendronate sodium - 59 seconds ago